Wilterding Mark (CIK 2107187) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy RXST (20,441 shares), Sell RXST (7,765 shares), Buy RXST (20,441 shares), Sell RXST (8,068 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | RxSight, Inc. (RXST) | Chief Financial Officer | Buy | 20,441 | $0 |
| 2026-09-02 | RxSight, Inc. (RXST) | Chief Financial Officer | Sell | 7,765 | $54,044 |
| 2026-03-03 | RxSight, Inc. (RXST) | Chief Financial Officer | Buy | 20,441 | $0 |
| 2026-03-03 | RxSight, Inc. (RXST) | Chief Financial Officer | Sell | 8,068 | $61,397 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02